Literature DB >> 15133767

The role of polyadenylation signal secondary structures on the resistance of plasmid vectors to nucleases.

Sofia C Ribeiro1, Gabriel A Monteiro, Duarte M F Prazeres.   

Abstract

BACKGROUND: Nuclease degradation of plasmid DNA (pDNA) vectors after delivery and during trafficking to the nucleus is a barrier to gene expression. This barrier may be circumvented by shielding the pDNA from the nuclease-rich cell environment with adjuvants or by using nuclease inhibitors. A different alternative that is explored in this work is to make pDNA vectors more nuclease-resistant a priori. METHODS AND
RESULTS: The hypothesis that a significant part of nuclease attack is directed towards certain labile sequences in a pDNA model (pVAX1/lacZ) was first tested. Homopurine-rich tracts in the bovine growth hormone polyadenylation signal (BGH poly A) were identified as labile sequences using S1 nuclease as a probe. Two pDNA variants were then created by replacing the BGH poly A region with the SV40 or a synthetic poly A signal. A study of plasmid degradation in eukaryotic cell lysates and mice plasma showed that the half-life of the supercoiled isoforms of the new vectors was always higher when compared with the control plasmid. An in vitro assay of the reporter beta-galactosidase in transfected CHO cells further showed that gene expression with the new pDNA variants was not affected negatively by the plasmid modifications.
CONCLUSIONS: The replacement of labile sequences in plasmid DNA vectors improves resistance towards nuclease attack as shown by the increased half-lives of supercoiled plasmid isoforms incubated with endo/lysosomal, cytoplasmatic and blood plasma enzymes. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133767     DOI: 10.1002/jgm.536

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  15 in total

1.  On the stability of plasmid DNA vectors during cell culture and purification.

Authors:  S S Freitas; A R Azzoni; J A L Santos; G A Monteiro; D M F Prazeres
Journal:  Mol Biotechnol       Date:  2007-06       Impact factor: 2.695

Review 2.  Rational vector design for efficient non-viral gene delivery: challenges facing the use of plasmid DNA.

Authors:  Juergen Mairhofer; Reingard Grabherr
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

3.  Polyplex-induced cytosolic nuclease activation leads to differential transgene expression.

Authors:  Rahul Rattan; Sriram Vaidyanathan; Gordon S-H Wu; Anisha Shakya; Bradford G Orr; Mark M Banaszak Holl
Journal:  Mol Pharm       Date:  2013-07-24       Impact factor: 4.939

4.  Comparative analysis of antigen-targeting sequences used in DNA vaccines.

Authors:  Joana A Carvalho; Adriano R Azzoni; Duarte M F Prazeres; Gabriel A Monteiro
Journal:  Mol Biotechnol       Date:  2010-03       Impact factor: 2.695

5.  Decline in exogenous gene expression in primate brain following intravenous administration is due to plasmid degradation.

Authors:  Chun Chu; Yun Zhang; Ruben J Boado; William M Pardridge
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

6.  Bioinformatics in new generation flavivirus vaccines.

Authors:  Penelope Koraka; Byron E E Martina; Albert D M E Osterhaus
Journal:  J Biomed Biotechnol       Date:  2010-05-10

7.  Time-course determination of plasmid content in eukaryotic and prokaryotic cells using real-time PCR.

Authors:  Elisabete Carapuça; Adriano R Azzoni; Duarte M F Prazeres; Gabriel A Monteiro; Filipe J M Mergulhão
Journal:  Mol Biotechnol       Date:  2007-10       Impact factor: 2.695

8.  Turning self-destructing Salmonella into a universal DNA vaccine delivery platform.

Authors:  Wei Kong; Matthew Brovold; Brian A Koeneman; Josephine Clark-Curtiss; Roy Curtiss
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-05       Impact factor: 11.205

Review 9.  Molecular-genetic imaging of cancer.

Authors:  Il Minn; Mitchell E Menezes; Siddik Sarkar; Keerthi Yarlagadda; Swadesh K Das; Luni Emdad; Devanand Sarkar; Paul B Fisher; Martin G Pomper
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

10.  Sonoporation increases therapeutic efficacy of inducible and constitutive BMP2/7 in vivo gene delivery.

Authors:  Georg A Feichtinger; Anna T Hofmann; Paul Slezak; Sebastian Schuetzenberger; Martin Kaipel; Ernst Schwartz; Anne Neef; Nikolitsa Nomikou; Thomas Nau; Martijn van Griensven; Anthony P McHale; Heinz Redl
Journal:  Hum Gene Ther Methods       Date:  2013-11-27       Impact factor: 2.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.